ANGELA FITCH: Open Payments
NPI 1811945959 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182,326 in 175 payments from 9 companies in 2025. Trend: 2023 $58,744 · 2024 $121,938 · 2025 $182,326
Speaker / faculty: $82,564Consulting: $56,396Travel & lodging: $36,475Food & beverage: $3,513Honoraria: $3,378
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 48 | $59,589 |
| Lilly USA, LLC | 72 | $55,524 |
| Currax Pharmaceuticals LLC | 20 | $34,187 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 23 | $16,885 |
| Eli Lilly and Company | 6 | $9,491 |
| Rhythm Pharmaceuticals, Inc. | 2 | $3,192 |
| ABBVIE INC. | 2 | $2,530 |
| PFIZER INC. | 1 | $900 |
| Amgen Inc. | 1 | $27 |
Products named: ZEPBOUND, Wegovy, CONTRAVE, Saxenda, Ozempic, MOUNJARO.
Industry payments across MA — which companies pay providers there.
